BIO Requested

No. 21-757

Amgen Inc., et al. v. Sanofi, et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Motion to extend the time to file a response is granted and the time is extended to and including March 14, 2022.

Motion to extend the time to file a response from February 10, 2022 to March 14, 2022, submitted to The Clerk.

Response Requested. (Due February 10, 2022)

DISTRIBUTED for Conference of 1/21/2022.

Brief amicus curiae of GlaxoSmithKline plc filed.

Brief amici curiae of Intellectual Property Professors filed.

Brief amici curiae of Association of University Technology Managers, Inc., et al.

Petition for a writ of certiorari filed. (Response due December 22, 2021)

Parties

Amgen Inc., et al., Petitioner, represented by Jeffrey Alan Lamken

Sanofi, et al., Respondent, represented by George William Hicks Jr.

Amici Curiae

Association of University Technology Managers, Inc., Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, Merck Sharp & Dohme Corp., and St. Jude Children’s Research Hospital, Inc., Amicus Curiae, represented by Jeffrey P. Kushan

GlaxoSmithKline plc, Amicus Curiae, represented by John M. Desmarais

Intellectual Property Professors, Amicus Curiae, represented by Mark A. Lemley

 
Last updated: January 26, 2022